Brand
Bristol-Myers Squibb Company
1 federal recall on file. We monitor every CPSC, FDA, USDA, and NHTSA notice for Bristol-Myers Squibb Company and translate it into plain English — free weekly digest, optional same-day alerts.
- 2025-10-29FDA-DrugClass IIOpdualag (nivolumab and relatlimab-rmbw) injection, 240 mg and 80 mg/20 mL (12mg and 4mg/mL),Single Dose Vial, RX Only, Bristol-Myers Squibb Company, Princeton, NJ 08543, NDC 0003-7125-11
Lack of Assurance of Sterility.
Get notified about new Bristol-Myers Squibb Company recalls
Free weekly digest. We email when a new federal recall affects Bristol-Myers Squibb Company or anything else in your household.
Get the Sunday BriefExplore other recall topics
By hazard
By state